Inatsuka CS - Search Results

1

Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

Inatsuka CS, Xu Q, Vujkovic-Cvijin I, Wong S, Stibitz S, Miller JF, Cotter PA. Inatsuka CS, et al. Infect Immun. 2010 Jul;78(7):2901-9. doi: 10.1128/IAI.00188-10. Epub 2010 Apr 26. Infect Immun. 2010. PMID: 20421378 Free PMC article.

2

Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity.

Inatsuka CS, Julio SM, Cotter PA. Inatsuka CS, et al. Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18578-83. doi: 10.1073/pnas.0507910102. Epub 2005 Dec 9. Proc Natl Acad Sci U S A. 2005. PMID: 16339899 Free PMC article.

3

Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation.

Henderson MW, Inatsuka CS, Sheets AJ, Williams CL, Benaron DJ, Donato GM, Gray MC, Hewlett EL, Cotter PA. Henderson MW, et al. Among authors: inatsuka cs. Infect Immun. 2012 Jun;80(6):2061-75. doi: 10.1128/IAI.00148-12. Epub 2012 Apr 2. Infect Immun. 2012. PMID: 22473603 Free PMC article.

4

Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection.

Julio SM, Inatsuka CS, Mazar J, Dieterich C, Relman DA, Cotter PA. Julio SM, et al. Among authors: inatsuka cs. Mol Microbiol. 2009 Mar;71(6):1574-90. doi: 10.1111/j.1365-2958.2009.06623.x. Epub 2009 Feb 10. Mol Microbiol. 2009. PMID: 19220744 Free PMC article.

5

Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.

Yang Y, Inatsuka C, Gad E, Disis ML, Standish LJ, Pugh N, Pasco DS, Lu H. Yang Y, et al. Innate Immun. 2014 Nov;20(8):857-66. doi: 10.1177/1753425913513814. Epub 2013 Dec 9. Innate Immun. 2014. PMID: 24323452 Free PMC article.

6

TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.

Lu H, Yang Y, Gad E, Inatsuka C, Wenner CA, Disis ML, Standish LJ. Lu H, et al. Clin Cancer Res. 2011 Nov 1;17(21):6742-53. doi: 10.1158/1078-0432.CCR-11-1142. Epub 2011 Sep 14. Clin Cancer Res. 2011. PMID: 21918170 Free PMC article.

7

Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.

Inatsuka C, Yang Y, Gad E, Rastetter L, Disis ML, Lu H. Inatsuka C, et al. Cancer Immunol Immunother. 2013 Aug;62(8):1335-45. doi: 10.1007/s00262-013-1436-4. Epub 2013 May 18. Cancer Immunol Immunother. 2013. PMID: 23685781 Free PMC article.

8

The invisible arm of immunity in common cancer chemoprevention agents.

Marzbani E, Inatsuka C, Lu H, Disis ML. Marzbani E, et al. Cancer Prev Res (Phila). 2013 Aug;6(8):764-73. doi: 10.1158/1940-6207.CAPR-13-0036. Cancer Prev Res (Phila). 2013. PMID: 23918793 Free PMC article. Review.

9

Bordetella filamentous hemagglutinin and adenylate cyclase toxin interactions on the bacterial surface are consistent with FhaB-mediated delivery of ACT to phagocytic cells.

Nash ZM, Inatsuka CS, Cotter PA, Johnson RM. Nash ZM, et al. Among authors: inatsuka cs. mBio. 2024 Mar 27:e0063224. doi: 10.1128/mbio.00632-24. Online ahead of print. mBio. 2024. PMID: 38534159 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page